JMAC Enterprises’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-7,616
| Closed | -$431K | – | 116 |
|
2024
Q4 | $431K | Buy |
7,616
+237
| +3% | +$13.4K | 0.07% | 141 |
|
2024
Q3 | $382K | Sell |
7,379
-2,217
| -23% | -$115K | 0.06% | 144 |
|
2024
Q2 | $399K | Sell |
9,596
-1,059
| -10% | -$44K | 0.07% | 138 |
|
2024
Q1 | $578K | Buy |
10,655
+121
| +1% | +$6.56K | 0.11% | 119 |
|
2023
Q4 | $541K | Sell |
10,534
-1,637
| -13% | -$84K | 0.12% | 119 |
|
2023
Q3 | $706K | Buy |
12,171
+1,245
| +11% | +$72.3K | 0.17% | 102 |
|
2023
Q2 | $699K | Buy |
10,926
+1,281
| +13% | +$81.9K | 0.17% | 101 |
|
2023
Q1 | $668K | Buy |
9,645
+872
| +10% | +$60.4K | 0.17% | 103 |
|
2022
Q4 | $631K | Sell |
8,773
-714
| -8% | -$51.4K | 0.17% | 105 |
|
2022
Q3 | $674K | Buy |
9,487
+121
| +1% | +$8.6K | 0.19% | 108 |
|
2022
Q2 | $721K | Sell |
9,366
-223
| -2% | -$17.2K | 0.19% | 107 |
|
2022
Q1 | $700K | Sell |
9,589
-6,835
| -42% | -$499K | 0.16% | 105 |
|
2021
Q4 | $1.08M | Buy |
+16,424
| New | +$1.08M | 0.25% | 89 |
|